44 Stocks Moving In Monday's Mid-Day Session

Gainers

• Intellia Therapeutics, Inc. NTLA shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy.
• Marin Software Incorporated MRIN gained 38.1% to $5.26. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
• Verve Therapeutics, Inc. VERV surged 30.2% to $46.84. The company recently priced its IPO at $19 per share.
• New Senior Investment Group Inc. SNR shares climbed 25% to $8.64. Ventas announced plans to acquire New Senior Investment Group in a transaction valued at $2.3 billion.
• IKONICS Corporation IKNX surged 19.8% to $22.24. The company, and TeraWulf, on Friday announced a merger agreement. IKONICS shareholders to receive $5 per share and contingent value right.
• Graybug Vision, Inc. GRAY gained 19.6% to $6.22.
• QAD Inc. QADA surged 19% to $86.73 after the company announced it will be acquired by Thoma Bravo for $2 billion, or $87.50 per share in cash.
• Graphite Bio, Inc. GRPH climbed 19% to $22.07. The company recently priced its IPO at $17 a share.
• ReShape Lifesciences Inc. RSLS rose 18.3% to $7.10.
• Mexco Energy Corporation MXC gained 15.8% to $10.43 after the company swung to a profit for FY21.
• Anavex Life Sciences Corp. AVXL shares jumped 15.1% to $28.48 after the company announced ANAVEX2-73 improved both primary cognitive and secondary MDS-UPDRS efficacy endpoints with significant biomarker correlation in placebo-controlled Phase 2 clinical trial for treatment of Parkinson's.
• Beam Therapeutics Inc. BEAM shares climbed 15% to $107.83.
• Perion Network Ltd. PERI jumped 14.7% to $21.40 after the company announced better-than-expected Q2 sales results and raised 2021 guidance.
• Grom Social Enterprises, Inc. GROM rose 14.3% to $3.9199.
• The9 Limited NCTY gained 14% to $15.34.
• X Financial XYF surged 14% to $17.17.
• Auddia Inc. AUUD gained 13.6% to $4.66.
• Iterum Therapeutics plc ITRM rose 13% to $2.3383 after gaining around 2% on Friday.
• JinkoSolar Holding Co., Ltd. JKS gained 12.5% to $48.35 after the company announced it has submitted the application documents regarding a potential initial public offering and listing of the shares of Jinko Solar Co., Ltd., the company's subsidiary.
• SilverSun Technologies, Inc. SSNT rose 11.4% to $12.43. Ault Global, last week, disclosed in a Form4 filing it bought 29,000 shares of the stock and sold 6,000 shares.
• IKONICS Corporation IKNX shares gained 10% to $20.42. IKONICS shares jumped 64% on Friday after the company, and TeraWulf, announced a merger agreement.
• CRISPR Therapeutics AG CRSP surged 7.1% to $152.57 amid positive data from peer company Intellia.
• MannKind Corporation MNKD surged 6.6% to $5.05 after the company announced Medicare patients will be able to use its Afrezza and continuous glucose monitoring devices starting in July.
• Precision BioSciences, Inc. DTIL gained 6.4% to $12.12 after the company dosed its first patient in an expanded phase 1/2a clinical trial for multiple myeloma.
• Bionano Genomics, Inc. BNGO gained 6% to $7.97 after the company announced it was added as a member of the US small-cap Russell 2000 Index.
• Kymera Therapeutics, Inc. KYMR gained 5.5% to $46.84 after the company announced KT-474 has achieved and exceeded Phase 1 target degradation of 85%within the SAD portion of the Phase 1 trial.
• Syndax Pharmaceuticals, Inc. SNDX jumped 4.6% to $19.20 after the company announced it was granted FDA Fast Track Designation for the treatment of acute leukemias.

Check out these big penny stock gainers and losers

Losers

• CEL-SCI Corporation CVM shares tumbled 42% to $14.58. CEL-SCI announced results from its Phase 3 study for its immunotherapy Multikine for advanced previously untreated squamous cell carcinoma of the head and neck (SCCHN).
• Kiromic BioPharma, Inc. KRBP fell 22.4% to $7.76. Kiromic Biopharma announced the company will be presenting at 2021 Next-Gen Immuno Oncology Congress showcasing its proprietary AI targets for off-the-shelf allogenic CAR-T for solid tumors.
• Exelixis, Inc. EXEL shares dipped 20.2% to $18.72 after the company provided a data update on its Phase 3 trial in patients with previously untreated advanced liver cancer.
• Meta Materials Inc. MMAT fell 20% to $7.93. Meta Materials closed transaction with Torchlight Energy Resources.
• Acurx Pharmaceuticals, Inc. ACXP fell 18.6% to $6.42. Acurx Pharmaceuticals shares climbed over 31% on Friday after the company priced its IPO at $6 per share.
• Oblong Inc. OBLG dipped 18.3% to $3.2350 after the company announced a $12.4 million registered direct offering.
• Grove, Inc. GRVI fell 14.5% to $6.72 after jumping 40% on Friday. The company, last week, priced its IPO at $5 per share.
• Tempest Therapeutics Inc. TPST fell 13.4% to $13.77.
• Atossa Therapeutics, Inc. ATOS fell 13.2% to $7.49 after gaining around 9% on Friday. The company is set to be included in the Russell 2000, 3000 indices, effective today.
• Greenland Technologies Holding Corporation GTEC fell 12.6% to $7.93 after the company priced its 857,844 share common stock offering at $8.16 per share.
• Bon Natural Life Limited BON fell 11.6% to $6.63. The company, last week, priced its IPO at $5 a share.
• Build-A-Bear Workshop, Inc. BBW declined 10.8% to $17.62.
• Osmotica Pharmaceuticals plc OSMT shares dropped 10.8% to $3.37. Osmotica Pharmaceuticals shares jumped 33% on Friday after the company agreed to sell its portfolio of legacy products and Georgia manufacturing facility, for up to $170 million, to Alora Pharmaceuticals LLC..
• Volt Information Sciences, Inc. VOLT dropped 10.2% to $4.82.
• Full Truck Alliance Co. Ltd. YMM declined 9.9% to $17.78.
• Missfresh MF shares fell 8.7% to $8.82. The company, on Friday, priced its IPO at $13 per share.
• Nevro Corp. NVRO dropped 5.7% to $168.47 after multiple firms lowered their respective price targets on the stock.